story of the week
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
N. Engl. J. Med 2023 Mar 27;[EPub Ahead of Print], MR Mirza, DM Chase, BM Slomovitz, R dePont Christensen, Z Novák, D Black, L Gilbert, S Sharma, G Valabrega, LM Landrum, LC Hanker, A Stuckey, I Boere, MA Gold, A Auranen, B Pothuri, D Cibula, C McCourt, F Raspagliesi, MS Shahin, SE Gill, BJ Monk, J Buscema, TJ Herzog, LJ Copeland, M Tian, Z He, S Stevens, E Zografos, RL Coleman, MA PowellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.